Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era

Journal of NeuroVirology

Volumn 16, Issue 1, 2010, Pages 25-32

  Cohen, Ronald A ^a   Harezlak, Jaroslaw ^b   Schifitto, Giovanni ^c   Hana, George ^a   Clark, Uraina ^a   Gongvatana, Assawin ^a   Paul, Robert ^d   Taylor, Michael ^e   Thompson, Paul ^f   Alger, Jeffery ^f   Brown, Mark ^g   Zhong, Jianhui ^c   Campbell, Thomas ^g   Singer, Elyse ^f   Daar, Eric ^h   McMahon, Deborah ⁱ   Tso, Yuen ^j   Yiannoutsos, Constantin T ^b   Navia, Bradford ^k  

^a BROWN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h HARBOR UCLA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

CD4 nadir; Cortical volume; Duration of infection; HAART; HIV; Subcortical volume; Viral load

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN SIZE; CD4 LYMPHOCYTE COUNT; DEMENTIA; DEMOGRAPHY; FEMALE; FRONTAL LOBE; GRAY MATTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIPPOCAMPUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER;

ADULT; AGE FACTORS; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAIN; CD4 LYMPHOCYTE COUNT; COMPUTER SIMULATION; FEMALE; HIV; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ORGAN SIZE; TIME FACTORS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77649304791     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280903552420     Document Type: Article

References (29)

1. Akaike H (1974). A new look at the statistical model identification. IEEE Trans Autom Control 19: 716-723.
2. Alemán-Gómez Y. Melie-García L, Valdés- Hernández P. IBASPM: Toolbox for automatic parcellation of brain structures. In: Presented at the 12th Annual Meeting of the Organization for Human Brain Mapping. Florence, Italy: Available on CD-Rom in NeuroImage. June 11-15, 2006, Vol.27, No.1.
3. Ances BM, Roc AC, Wang J, Korczykowski M, Okawa J, Stern J, Kim J, Wolf R, Lawler K, Kolson DL, Detre JA (2006). Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology 66: 862-866.
4. Aylward EH, Brettschneider PD, McArthur JC, Harris GJ, Schlaepfer TE, Henderer JD, Barta PE, Tien AY, Pearlson GD (1995). Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152: 987-994.
5. Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, Barta PE, Pearlson GD (1993). Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43: 2099-2104.
6. Brew BJ (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1): S75-S78.
7. Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2008). Neurodegeneration and Ageing in the HAART Era. J Neuroimmune Pharmacol. 4: 163-174.
8. Burnham K, Anderson DR (2002). Model selection and multimodel inference: a practical-theoretic approach, 2nd ed. New York: Springer-Verlag.
9. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA (2000). Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283: 381-390. (Pubitemid 30051757)
10. Chang L, Tomasi D, Yakupov R, Lozar C, Arnold S, Caparelli E, Ernst T (2004). Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol 56: 259-272.
11. Dore G, Correll P, Li Y, Kaldor J, Cooper D, Brew B (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13: 1249-1253.
12. Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J NeuroVirol 15: 187-195.
13. Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA (1994). The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol 51: 1129-1135.
14. Jernigan TL, Archibald S, Hesselink JR, Atkinson JH, Velin RA, McCutchan JA, Chandler J, Grant I (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol 50: 250-255.
15. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65-70.
16. Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG (2003). Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology 60: 1467-1473.
17. Masliah E, DeTeresa RM, Mallory ME, Hansen LA (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14: 69-74.
18. McArthur JC (2004). HIV dementia: an evolving disease. J Neuroimmunol 157: 3-10.
19. Patel SH, Inglese M, Glosser G, Kolson DL, Grossman RI, Gonen O (2003). Whole-brain N-acetylaspartate level and cognitive performance in HIV infection. AJNR Am J Neuroradiol 24: 1587-1591.
20. Patel SH, Kolson DL, Glosser G, Matozzo I, Ge Y, Babb JS, Mannon LJ, Grossman RI (2002). Correlation between percentage of brain parenchymal volume and neuro-cognitive performance in HIV-infected patients. AJNR Am J Neuroradiol 23: 543-549.
21. Paul R, Cohen R, Navia B (2002). Neuroimaging relationships to cognition in patients with HIV. Neurosci Biobehav Rev 26: 353-359.
22. Paul RH, Ernst T, Brickman AM, Yiannoutsos CT, Tate DF, Cohen RA, Navia BA (2008). Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. J Int Neuropsychol Soc 14: 725-733.
23. Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, Lenkinski RE, Cohen RA, Navia BA (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuro-psychiatry Clin Neurosci 19: 283-292.
24. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J Neuro-Virol 8: 136-142.
25. Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT (2005). Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci USA 102: 15647-15652.
26. Thurnher MM, Schindler EG, Thurnher SA, Pernerstorfer-Schon H, Kleibl-Popov C, Rieger A (2000). Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol 21: 670-678.
27. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273-289.
28. Valcour V, Sacktor N (2002). HIV-associated dementia and aging. J Ment Health Aging 8: 295-306.
29. Valcour V, Shikuma C, Waters M, Sacktor N (2004). Cognitive impairment in older HIV-1 seropositive individuals: prevalence and potential mechanisms. AIDS 18(Suppl 1): S79-S86.